CoChat

Maternal Urinary Phthalates and Phenols and Male Genital Anomalies

Open access
Chevrier, Cécile, Petit, Claire, Philippat, Claire, Mortamais, Marion, Slama, Rémy, Rouget, Florence, Calafat, Antonia M., Ye, Xiaoyun, Silva, Manori J., Charles, Marie-Aline, Cordier, Sylvaine · 2012 · Epidemiology
Cited by 80

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

To the Editor: Concerns have been raised about adverse health effects from ubiquitous exposure during pregnancy to phthalates and phenols. Toxicologic data suggest that some of these compounds can disrupt the hormonal signaling that regulates male genital organogenesis. Evidence from the epidemiologic literature assessing association between in utero exposure to these compounds and male genital anomalies is limited and inconclusive.1–3 We evaluated whether prenatal exposure to select phthalates and phenols was associated with occurrence of hypospadias and undescended testes in a case-control study (eTable 1, https://links.lww.com/EDE/A558) nested in the EDEN and PELAGIE mother–child cohorts (5200 pregnant women).4 Cases of hypospadias (n = 21) and undescended testis (unilateral or bilateral, not in scrotum, n = 50) were identified during the first days after birth by pediatricians or midwives. Three controls per case were selected among male singleton live births, matched with cases for residence area, gestational age at urine sample collection, and date and day of collection (Sunday–Monday vs. other). Urinary concentrations of 11 phthalate metabolites and 9 phenols (samples collected in the morning, eTable 2, https://links.lww.com/EDE/A558), determined without knowledge of case-control status, were standardized by sampling conditions that varied among participants using a 2-step standardization method based on regression residuals as described previously.4 As an alternative exposure metric, we used a specific job-exposure matrix (JEM).2,3 In all, 13 women (9%) were classified as possibly exposed to phthalates in the workplace. No correlation between occupational exposure to phthalates and the urinary concentrations of phthalate metabolites was seen (eTable3, https://links.lww.com/EDE/A558). Due to the short-lived nature of these compounds, the morning urinary biomarkers do not necessarily capture occupational exposures, such that both exposure metrics might reflect complementary exposure sources. Using conditional logistic regression, we observed slightly reduced risks of hypospadias with increasing urinary concentrations of all phthalate metabolites (Table, eTable4, https://links.lww.com/EDE/A558). Increased risk of undescended testis was observed in association with the second or third tertiles of urinary concentrations of bisphenol A (BPA), 2,4-dichlorophenol, and ethylparaben compared with the first tertile (Table); increases were more pronounced among term boys (eTable5, https://links.lww.com/EDE/A558). The odds ratio (OR) for hypospadias associated with possible maternal occupational exposure to phthalates was 4.2 (95% confidence interval [CI] 0.4–41.3; 2 exposed cases and 2 exposed matched controls), whereas the OR for undescended testes was 0.3 (0.0–3.1; 1 exposed case and 6 exposed matched controls). A possible role of co-occurring compounds in the corresponding occupations (n = 9 hairdressers in our study) cannot be discarded.Table: ORs for Undescended Testis and Hypospadias According to Tertiles of Urinary Concentrations of Phthalate Metabolites and PhenolsThe main limitation of our study was the modest sample size, especially for results concerning phenols (available only in the EDEN cohort). Despite consistency with their estrogenic molecular activity, findings reported for phenols are subject to special caution because they are not supported by animal data. The use of a single spot urine sample may not efficiently reflect the average level of weekly or monthly exposure for compounds such as di(2-ethylhexyl) phthalate (DEHP) and BPA with an important dietary pathway,5–7 but it provides reliable exposure measures for low-molecular-weight phthalates and parabens, likely due to regular use of personal-care products.5,7 Our prospective study did not show evidence of increased risks of male genital anomalies with prenatal exposure to phthalates. We did not confirm the inverse relation between prenatal DEHP exposure and testicular descent (assessed at approximately 1 year old) previously suggested by a study relying on 12 cases1; both the earlier study and our study found no increased risk for other phthalates.1 In contrast, we observed an unexpected decrease in the risk of hypospadias with increased concentrations of maternal urinary phthalate metabolites, for which we have no clear explanation. We speculate on a possible role of PPAR (peroxisome proliferator-activated receptors) ligands (known for some phthalates) and its critical role in placenta development, as previously proposed.8 Cécile Chevrier Claire Petit IRSET Inserm University Rennes I Rennes, France [email protected] Claire Philippat Marion Mortamais Rémy Slama Inserm U823 Team of Environmental Epidemiology applied to Reproduction and Respiratory Health Institut Albert Bonniot University Joseph Fourier Grenoble Grenoble, France Florence Rouget IRSET Inserm “Bien naître en Ille-et-Vilaine” Perinatal Network Rennes, France Antonia M. Cala

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ede.0b013e318246073e

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Chevrier, C., Petit, C., Philippat, C., Mortamais, M., Slama, R., Rouget, F., Calafat, A. M., Ye, X., Silva, M. J., Charles, M.-A., & Cordier, S.
Venue
Epidemiology
Published
2012-03
Volume
23
Issue
2
Pages
353-356
ISSN
1044-3983 (ISSN-L)
OpenAlex
W2041697361
Cited by
80
References
1
FWCI
5.38
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.